High-dose olanzapine in treatment-resistant schizophrenia: a systematic review

• Main Authors: Louisa Gannon (Author), John Reynolds (Author), Martin Mahon (Author), Fiona Gaughran (Author), John Lally (Author)
• Formato: Livro
• Publicado em: SAGE Publishing, 2023-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Treatment-resistant schizophrenia (TRS) affects approximately 30% of people with schizophrenia. Clozapine is the gold standard treatment for TRS but is not always suitable, with a proportion of individuals intolerant of side effects or unable to engage in necessary blood monitoring. Give...